Gail Morgan, the former public affairs and strategy head at Medicines Australia (MA), has been appointed as the first chief executive officer of the Medicinal Cannabis Council Australia (MCCA). [1, 2]
Strategic Appointment Details
- The Role: Her appointment as the inaugural CEO marks a significant milestone in professionalising and scaling Australia’s medicinal cannabis sector. [1]
- Prior Experience: Morgan has over 30 years of health and medicines landscape experience. She previously served as the Head of Strategy and Government Relations at Medicines Australia, CEO of Osteoporosis Australia, and held senior roles within the Commonwealth Department of Parliamentary Services. [1]
- Key Focus Areas: According to MCCA Chair Geoff Bloom, Morgan will lead efforts to deepen engagement with government body representatives, healthcare professionals, and key industry stakeholders. Her expertise will guide the sector through heightening regulatory scrutiny and evolving market demands.
Google AI
